Council approves FP7

The Seventh Framework Programme for research and technological development (FP7) cleared its final hurdle on 18 December when it was adopted by the Council. The programme will start on 1 January 2007.

The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

The Council also adopted a regulation setting out the rules for participation in FP7 by companies, research institutes and universities, and on the dissemination of research results.

The total budget for FP7 is €50.521 billion, and the programme will run for seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years.

FP7 will be implemented through four specific programmes:

  • Cooperation - collaborative research;
  • Ideas - the establishment of a European Research Council (ERC) to support frontier research;
  • People - human resources;
  • Capacities - research infrastructure and potential research capacity.

The first calls for proposals are due on 22 December.

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

The European Commission first submitted its proposals on FP7 in April 2005.

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/home_en.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...